Phase 2b Trial for Cancer Vaccine in Newly Diagnosed Glioblastoma Will Continue
Tumor‑treating fields (TTFields) combined with temozolomide significantly improve progression‑free and overall survival in newly diagnosed supratentorial glioblastoma patients.
Evidence level: Irányelv / elfogadott gyakorlat. Magas szintű klinikai elfogadottság.
Related signals
- Glioma
- Glioblastoma Clinical Trials for New Treatments
- Clinical trial links oncolytic immunoactivation to survival in glioblastoma
- Tumour treating fields therapy for glioblastoma: current advances and future directions
- Treating the invisible target: treatment planning targeting the microscopic tumor spread in gliomas